Table 1.
Demographic and clinical profiles of pregnant women co-infected with P. vivax and SARS-CoV-2
| Variables | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 |
|---|---|---|---|---|---|
| Demographical | |||||
| Age, years | 25 | 28 | 21 | 15 | 20 |
| Occupation | Cook in mining camp | Housewife | Housewife | Student | Housewife |
| Trimester of pregnancy | Third trimester | Third trimester | Second trimester | Second trimester | Third trimester |
| Previous pregnancies, no | 2 | 2 | 2 | 0 | 1 |
| Clinical | |||||
| Comorbidities | Obesity | Hypertension | Obesity | No | Asthma |
| COVID-19 severity | Moderate | Severe | Critical | Critical | Mild |
| Previous malaria episodes, no | 7 | 3 | 1 | 0 | 2 |
| Past malaria parasite | P. vivax | P. vivax | P. vivax | – | Mixed |
| Maternal complications | No | Preeclampsia | Cerebral malaria | Hyperemesis gravidarum | No |
| Fetal complications | Stillbirth | No | Miscarriage | Miscarriage | No |
| Maternal outcome | Discharge | Discharge | Death | Death | Discharge |
| Fetal outcome (gestational age) | Death (week 29) | Live birth (week 30) | Death (week 20) | Death (week 16) | Live birth (week 38) |
| Newborn’s weight, g | – | 1305 | – | – | 2949 |
| Newborn’s APGAR at 5th minute, points | – | 4 | – | – | 9 |
| Hospital stay, days | 1 | 17 | 2 | 0 | 7 |
COVID-19 coronavirus disease 2019